Novo Integrated Sciences, Inc. Net Change in Cash
Novo Integrated Sciences, Inc. reported Net Change in Cash of $428.26 thousand for the 12-month period ending 2024-08-31, per its 10-K filed 2024-12-18.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-12-18
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-11-30 was $1.22M.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-11-30 was -$1.30M, a 356.11% decline year-over-year.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-11-30 was $507.59K.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-11-30 was -$97.33K.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $428.26K.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$1.76M.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$6.11M, a 198.22% decline from fiscal 2021.
- Novo Integrated Sciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $6.23M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-08-31 | $428.26K 10-K · filed 2024-12-18 | |||
| 2024-05-31 | $1.12M 10-Q · filed 2024-07-19 | |||
| 2024-02-29 | $235.42K 10-Q · filed 2024-04-15 | |||
| 2023-11-30 | $1.22M 10-Q · filed 2024-01-22 | |||
| 2023-08-31 | -$1.76M 10-K · filed 2024-12-18 | |||
| 2023-05-31 | -$1.71M 10-Q · filed 2024-07-19 | |||
| 2023-02-28 | -$1.57M 10-Q · filed 2024-04-15 | |||
| 2022-11-30 | -$1.30M 10-Q · filed 2024-01-22 | |||
| 2022-08-31 | -$6.11M 10-K · filed 2023-12-14 | |||
| 2022-05-31 | $4.38M 10-Q · filed 2023-07-17 | |||
| 2022-02-28 | $7.65M 10-Q · filed 2023-05-26 | |||
| 2021-11-30 | $507.59K 10-Q · filed 2023-05-24 | |||
| 2021-08-31 | $6.23M 10-K · filed 2023-04-03 | |||
| 2021-05-31 | $6.30M 10-Q · filed 2022-07-14 | |||
| 2021-02-28 | -$369.28K 10-Q · filed 2022-04-13 | |||
| 2020-11-30 | -$97.33K 10-Q · filed 2022-01-18 | |||
| 2020-08-31 | -$15.95K 10-K · filed 2021-12-14 | |||
| 2020-05-31 | -$689.30K 10-Q · filed 2021-07-14 | |||
| 2020-02-29 | -$874.33K 10-Q · filed 2021-04-14 | |||
| 2019-11-30 | -$151.96K 10-Q · filed 2021-01-13 | |||
| 2019-08-31 | $1.41M 10-K · filed 2020-12-09 | |||
| 2019-05-31 | $1.80M 10-Q · filed 2020-07-14 | |||
| 2019-02-28 | $1.70M 10-Q · filed 2020-04-20 | |||
| 2018-11-30 | $253.43K 10-Q · filed 2020-01-13 | |||
| 2018-08-31 | -$1.22M 10-K · filed 2019-11-20 |